Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Maurice

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
The British Journal of Radiology|January 1, 1989
Technetium-99m hydroxymethylene diphosphonate scanning of acute injuries to the lateral ligaments of the ankleH Maurice, I Watt
Molecular Pharmacology|July 25, 2000
Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissuesD Palmer, D H Maurice
British Journal of Pharmacology|January 12, 1999
Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMPH Liu, D H Maurice
The Journal of Biological Chemistry|April 3, 1999
Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targetingH Liu, D H Maurice
Cells|November 24, 2019
An EPAC1/PDE1C-Signaling Axis Regulates Formation of Leading-Edge Protrusion in Polarized Human Arterial Vascular Smooth Muscle CellsPaulina Brzezinska, Donald H Maurice
Molecular Pharmacology|August 16, 2002
Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivoDouglas G Tilley, Donald H Maurice
Molecular Pharmacology|June 7, 2005
Vascular smooth muscle cell phenotype-dependent phosphodiesterase 4D short form expression: role of differential histone acetylation on cAMP-regulated functionDouglas G Tilley, Donald H Maurice
Molecular Pharmacology|May 1, 1990
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMPD H Maurice, R J Haslam
Canadian Journal of Physiology and Pharmacology|August 27, 2020
Phosphodiesterase 4D7 selectively regulates cAMP-mediated control of human arterial endothelial cell transcriptomic responses to fluid shear stressJonah Burke-Kleinman, Donald H Maurice
American Journal of Physiology. Endocrinology and Metabolism|May 12, 2005
Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complexHisham S Elbatarny, Donald H Maurice
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
The British Journal of Radiology|January 1, 1989
Technetium-99m hydroxymethylene diphosphonate scanning of acute injuries to the lateral ligaments of the ankleH Maurice, I Watt
Molecular Pharmacology|July 25, 2000
Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissuesD Palmer, D H Maurice
British Journal of Pharmacology|January 12, 1999
Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMPH Liu, D H Maurice
The Journal of Biological Chemistry|April 3, 1999
Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targetingH Liu, D H Maurice
Cells|November 24, 2019
An EPAC1/PDE1C-Signaling Axis Regulates Formation of Leading-Edge Protrusion in Polarized Human Arterial Vascular Smooth Muscle CellsPaulina Brzezinska, Donald H Maurice
Molecular Pharmacology|August 16, 2002
Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivoDouglas G Tilley, Donald H Maurice
Molecular Pharmacology|June 7, 2005
Vascular smooth muscle cell phenotype-dependent phosphodiesterase 4D short form expression: role of differential histone acetylation on cAMP-regulated functionDouglas G Tilley, Donald H Maurice
Molecular Pharmacology|May 1, 1990
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMPD H Maurice, R J Haslam
Canadian Journal of Physiology and Pharmacology|August 27, 2020
Phosphodiesterase 4D7 selectively regulates cAMP-mediated control of human arterial endothelial cell transcriptomic responses to fluid shear stressJonah Burke-Kleinman, Donald H Maurice
American Journal of Physiology. Endocrinology and Metabolism|May 12, 2005
Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complexHisham S Elbatarny, Donald H Maurice
Pageof 13